Skip to main content

Table 2 Projected uptake rates of epoetin SEB in Canada, years 1 to 5

From: A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada

Epoetin SEB uptake rates

Year 1

Year 2

Year 3

Year 4

Year 5

1%

4%

7%

11%

14%

  1. SEB = subsequent entry biologic.